ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2025, Vol 15, No. 3

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of integrative fields within Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Why Publish with APB?

Free of charge publication for all article types
Fast and constructive peer review
Simple and efficient online submission
Author-friendly review process
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Review Article

1. Covid 19-the 21st Century Pandemic: The Novel Coronavirus Outbreak and the Treatment Strategies

Sherin Joseph , Anila Kutty Narayanan*

Adv Pharm Bull. 2022;12(1): 34-44. doi: 10.34172/apb.2022.005

PMCID: PMC9012918 PMID: 35517888 Scopus ID: 85127157166

Article

PDF

Full Text

XML

Cited By:

Editorial

2. Mesenchymal Stem Cells in the Treatment of New Coronavirus Pandemic: A Novel Promising Therapeutic Approach

Sara Razi , Zahra Molavi, Seyed Amir Mirmotalebisohi, Zahra Niknam, Marzieh Sameni, Vahid Niazi, Amirjafar Adibi, Mohsen Yazdani, Mohammad Mehdi Ranjbar, Hakimeh Zali*

Adv Pharm Bull. 2022;12(2): 206-216. doi: 10.34172/apb.2022.023

PMCID: PMC9106958 PMID: 35620342 Scopus ID: 85122964899

Article

PDF

Full Text

XML

Cited By:

Editorial

3. Renin Angiotensin System and Covid-19 Infection

Francesco Ferrara* , Antonio Vitiello

Adv Pharm Bull. 2022;12(1): 1-4. doi: 10.34172/apb.2022.001

PMCID: PMC9012934 PMID: 35517880 Scopus ID: 85127162469

Article

PDF

Full Text

XML

Cited By:

Review Article

4. Coenzyme Q10 and Its Therapeutic Potencies Against COVID-19 and Other Similar Infections: A Molecular Review

Mohammad Fakhrolmobasheri , Mahnaz-Sadat Hosseini, Seyedeh-Ghazal Shahrokh, Zahra Mohammadi, Mohammad-Javad Kahlani, Seyed-Erfan Majidi, Mehrdad Zeinalian*

Adv Pharm Bull. 2023;13(2): 233-243. doi: 10.34172/apb.2023.026

PMCID: PMC10278218 PMID: 37342382

Article

PDF

Full Text

XML

Cited By:

Research Article

5. The Potential of Vouacapanes from Pterodon emarginatus Vogel Against COVID-19 Cytokine Storm

Leandra de Almeida Ribeiro Oliveira , Arthur Christian Garcia da Silva, Douglas Vieira Thomaz , Fabiana Brandão , Edemilson Cardoso da Conceição , Marize Campos Valadares , Maria Tereza Freitas Bara* , Dâmaris Silveira*

Adv Pharm Bull. 2023;13(1): 150-159. doi: 10.34172/apb.2023.016

PMCID: PMC9871284 PMID: 36721819

Article

PDF

Full Text

XML

Cited By:

Editorial

6. Promising Adjunct Medicines in the Protocol of COVID-19 Clinical Trial

Mona Mahmoud AbouSamra* , Soheir Said Mansy

Adv Pharm Bull. 2022;12(4): 641-644. doi: 10.34172/apb.2022.067

PMCID: PMC9675919 PMID: 36415639 Scopus ID: 85140272968

Article

PDF

Full Text

XML

Cited By:

Systematic Review

7. ChAdOx1 nCoV-19 Vaccine and Thrombosis with Thrombocytopenia Syndrome among Adults: A Systematic Review

Homa Faghihi , Negar Mottaghi-Dastjerdi* , Mohammad Sharifzadeh, Nader Rahimi Kakavandi

Adv Pharm Bull. 2023;13(4): 723-735. doi: 10.34172/apb.2023.081

PMCID: PMC10676559 PMID: 38022808

Article

PDF

Suppl 1

Full Text

XML

Cited By:

Review Article

8. Targeting Viral ORF3a Protein: A New Approach to Mitigate COVID-19 Induced Immune Cell Apoptosis and Associated Respiratory Complications

Minu Treeza M , Sanu Augustine , Aparna Ann Mathew , S.K. Kanthlal* , Rajitha Panonummal*

Adv Pharm Bull. 2023;13(4): 678-687. doi: 10.34172/apb.2023.069

PMCID: PMC10676557 PMID: 38022818

Article

PDF

Full Text

XML

Cited By:

Review Article

9. Recent Update of COVID-19 Vaccines

Sameer A. Jadaan* , Abdul Waheed Khan

Adv Pharm Bull. 2022;12(2): 219-236. doi: 10.34172/apb.2022.045

PMCID: PMC9106961 PMID: 35620327 Scopus ID: 85128147762

Article

PDF

Full Text

XML

Cited By:

Original Article

10. Inhibitory Effects of Citrus-Derived Flavonoids Hesperidin and Hesperetin on SARS-CoV-2 Spike-Mediated Syncytia Formation Using In Vitro Cell Model

Dennaya Kumara , Hayfa Salsabila Harsan, Endah Puji Septisetyani* , Pekik Wiji Prasetyaningrum , Komang Alit Paramitasari , Mukh Syaifudin , Okid Parama Astirin , Muthi Ikawati , Edy Meiyanto

Adv Pharm Bull. 2025;15(2): 416-427. doi: 10.34172/apb.44060

PMCID: PMC12413959 PMID: 40922737

Article

PDF

Full Text

XML

Cited By:

Short Communication

11. Long and Short-term Metformin Consumption as a Potential Therapy to Prevent Complications of COVID-19

Elnaz Shaseb , Saba Ghaffary* , Alireza Garjani, Elnaz Zoghi, Nasrin Maleki Dizaji, Somaieh Soltani, Parvin Sarbakhsh, Mohammad Hossein Somi, Parya Valizadeh, Ali Taghizadieh, Masood Faghihdinevari, Mojtaba Varshochi, Behrooz Naghily, Zhinous Bayatmakoo, Parviz Saleh, Sepehr Taghizadeh, Mehdi Haghdoost, Hamid Owaysi, Fatemeh Ravanbakhsh Ghavghani, Mohammad Kazem Tarzamni, Rojin Moradi, Fateme Javan Ali Azar, Saeid Shabestari Khiabani, Ardavan Ghazanchaei, Sana Hamedani, Shahabeddin Hatefi

Adv Pharm Bull. 2023;13(3): 621-626. doi: 10.34172/apb.2023.066

PMCID: PMC10460805 PMID: 37646067

Article

PDF

Full Text

XML

Cited By: